Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a plays a central role in the production of blood cells in the bone marrow. It is assembling a portfoli... Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a plays a central role in the production of blood cells in the bone marrow. It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematological malignancies. Show more
- Investigator-initiated trial (IIT) to be led by pioneers of cell therapy in B-cell mediated autoimmune disease, the Schett/Mackensen group at Friedrich-Alexander University Erlangen-Nürnberg...
PHILADELPHIA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in...
– Expansion of Phase 1 CALiPSO-1 trial of CNTY-101 in autoimmune disease to include diffuse cutaneous systemic sclerosis and idiopathic inflammatory myopathy – – Overall response rate (ORR) of...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0532 | -5.26732673267 | 1.01 | 1.01 | 0.8693 | 422377 | 0.92425759 | CS |
4 | -0.0632 | -6.19607843137 | 1.02 | 1.18 | 0.8693 | 476880 | 1.01391277 | CS |
12 | -0.4232 | -30.6666666667 | 1.38 | 1.83 | 0.8693 | 620799 | 1.25616653 | CS |
26 | -1.3832 | -59.1111111111 | 2.34 | 2.55 | 0.8693 | 452299 | 1.4256694 | CS |
52 | -2.8532 | -74.8871391076 | 3.81 | 5.51 | 0.8693 | 335641 | 2.10623928 | CS |
156 | -12.0232 | -92.6286594761 | 12.98 | 15.375 | 0.8693 | 196780 | 3.84820527 | CS |
260 | -18.5432 | -95.0933333333 | 19.5 | 32.899 | 0.8693 | 193705 | 6.90003762 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales